Although it had a small sample size, our m-fIHC analysis confirmed the significant increase in CD4+ T-lymphocytes (CD3+/CD8−) in the tumor area of TIL-B-rich tumors, while CD8+ T-lymphocyte and CD163+ macrophage infiltration levels were comparable (Figure 5B). The gene discussed is CD4; the disease is neoplasm.